Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI

Cyclophosphamide in combination with busulfan (Bu) or total body irradiation (TBI) are the most commonly used myeloablative conditioning regimens in patients with Chronic Myeloid Leukemia (CML). We used data from the Center for International Bone Marrow Transplantation Research to compare outcomes i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Copelan, Edward A., Avalos, Belinda, Ahn, Kwang Woo, Zhu, Xiaochun, Gale, Robert Peter, Grunwald, Michael R., Hamadani, Mehdi, Hamilton, Betty K., Hale, Gregory A., Marks, David I., Waller, Edmund K., Savani, Bipin N., Costa, Luciano J., Ramanathan, Muthalagu, Cahn, Jean-Yves, Khoury, H. Jean, Weisdorf, Daniel J., Inamoto, Yoshihiro, Kamble, Rammurti T., Schouten, Harry C., Wirk, Baldeep, Litzow, Mark R., Aljurf, Mahmoud D., van Besien, Koen W., Ustun, Celalettin, Bolwell, Brian J., Bredeson, Christopher N., Fasan, Omotayo, Ghosh, Nilanjan, Horowitz, Mary M., Arora, Mukta, Szer, Jeffrey, Loren, Alison W., Alyea, Edwin P., Cortes, Jorge, Maziarz, Richard T., Kalaycio, Matt E., Saber, Wael
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329042/
https://ncbi.nlm.nih.gov/pubmed/25528388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.12.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars